Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Motixafortide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2AYRMID PHARMA

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    AYRMID PHARMA

    MOTIXAFORTIDE ACETATE

    arrow
    APS Symposium
    Not Confirmed

    AYRMID PHARMA

    Country
    arrow
    APS Symposium
    Not Confirmed

    Patent Expiration Date : 2041-12-29

    MOTIXAFORTIDE ACETATE

    US Patent Number : 12257285

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 217159

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2041-12-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AYRMID PHARMA

    MOTIXAFORTIDE ACETATE

    arrow
    APS Symposium
    Not Confirmed

    AYRMID PHARMA

    Country
    arrow
    APS Symposium
    Not Confirmed

    Patent Expiration Date : 2041-12-29

    MOTIXAFORTIDE ACETATE

    US Patent Number : 12268725

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 217159

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2041-12-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF